SFRP2 and pulmonary fibrosis: Furthermore, therapeutic intervention with AAV6-sh<i>Sfrp2</i>, SFRP2-neutralizing antibody, or the autophagy inducer rapamycin significantly ameliorated lung fibrosis in bleomycin (BLM)-induced mouse models.